Microbot Medical announces it had successfully completed the Electromagnetic Compatibility, or EMC, testing section of the Verification and Validation, or V&V, process. “The success in completing the EMC testing of our V&V testing, we believe, affirms our dedication to ensuring the highest quality and safety standards for our LIBERTY Robotic Surgical System. We plan on completing the on-going additional testing required by the V&V process, in the near future, with the goal to commence our first clinical trial in the US,” said Simon Sharon, the company’s CTO & GM.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MBOT:
- Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
- Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
- Microbot Medical granted registered trademark from USPTO
- Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
- Microbot Medical reveals short term follow up outcomes from preclinical study
